RANI vs V · rev $1.0M vs P/E 33, rev $40.00B
Rani Therapeutics Holdings Inc (RANI) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
RANI currently screens at market cap $41.5M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the RANI and V stock pages for the full models.
Not investment advice.